CDK5 and ovarian carcinoma: This hypothesis is further supported by results reported in CDK5-inhibited HCC cells [14] and CDK5-depleted ovarian cancer cell lines [15], in which cancer cells exhibit higher sensitivity to DNA-damaging agents.